Walter H. Moos

CIK: 0001190272

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)1 (25.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RIGL

RIGEL PHARMACEUTICALS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

RIGL
RIGEL PHARMACEUTICALS INC
May 15, 2026
Award(A)
Direct
5.8K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Feb 20, 2026
Exercise(M)
Direct
4K shares at avg. $24.00$96K
RIGL
RIGEL PHARMACEUTICALS INC
Feb 20, 2026
Sale(S)
Direct
4K shares at avg. $36.36$145K
RIGL
RIGEL PHARMACEUTICALS INC
May 23, 2025
Award(A)
Direct
2.5K shares-

		Type	Shares	Price		Ownership
May 15, 2026	RIGL RIGEL PHARMACEUTICALS INC	Award(A)	5,750	-	$0	Direct
Feb 20, 2026	RIGL RIGEL PHARMACEUTICALS INC	Exercise(M)	4,000	$24.00	$96,000	Direct
Feb 20, 2026	RIGL RIGEL PHARMACEUTICALS INC	Sale(S)	4,000	$36.36	$145,440	Direct
May 23, 2025	RIGL RIGEL PHARMACEUTICALS INC	Award(A)	2,500	-	-	Direct

1-4 of 4 transactions

About MOOS WALTER H

MOOS WALTER H (SEC CIK 0001190272) files insider reports with the SEC as Director of RIGEL PHARMACEUTICALS INC (RIGL).

Signal8 holds 3 ownership filings by MOOS WALTER H, all Form 4s, filed between May 28, 2025 and May 19, 2026. Those filings report 4 transactions, from May 23, 2025 to May 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MOOS WALTER H's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by MOOS WALTER H

May 15, 2026: Grant or award of RIGL shares (Form 4, code A).
Feb 20, 2026: Option exercise of RIGL shares (Form 4, code M).
Feb 20, 2026: Open-market sale of RIGL shares (Form 4, code S).
May 23, 2025: Grant or award of RIGL shares (Form 4, code A).

Other insiders filing for RIGEL PHARMACEUTICALS INC (RIGL)

Schorno Dean L, EVP & Chief Financial Officer
Santos David A, EVP, Chief Commercial Officer
RODRIGUEZ RAUL R, CEO, President
Furey Raymond J., EVP, GC, CCO & Corp Sec
HANNAH ALISON L., EVP, Chief Medical Officer
Ali-Jackson Kamil, Director

How to read Form 4 transaction codes